The failure to complete a viable BLA is due to a CRO that was either grossly negligent and incompetent, or a Saboteur. The CEO was chastising a vendor. This will come out in court. Leronlimab has an unmatched safety profile and shows excellent efficacy against mTNBC, NASH, and HIV. The negative narrative is too transparent. It is becoming less effective by the day.
Market Data 
Markets 
AI
